Jonathan Karn
#157,299
Most Influential Person Now
Researcher ORCID ID = 0000-0002-2900-094X
Jonathan Karn's AcademicInfluence.com Rankings
Jonathan Karnbiology Degrees
Biology
#12191
World Rank
#15651
Historical Rank
Virology
#293
World Rank
#300
Historical Rank
Cell Biology
#637
World Rank
#650
Historical Rank
Genetics
#1328
World Rank
#1430
Historical Rank
Download Badge
Biology
Jonathan Karn's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Jonathan Karn Influential?
(Suggest an Edit or Addition)Jonathan Karn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nucleotide sequence of tobacco mosaic virus RNA. (1982) (586)
- Toward a physical map of the genome of the nematode Caenorhabditis elegans. (1986) (569)
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) (476)
- Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. (1989) (416)
- Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle (1982) (416)
- Transcriptional and posttranscriptional regulation of HIV-1 gene expression. (2012) (382)
- The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. (1995) (337)
- HIV‐1 tat protein stimulates transcription by binding to a U‐rich bulge in the stem of the TAR RNA structure. (1990) (336)
- Novel bacteriophage lambda cloning vector. (1980) (273)
- Periodic features in the amino acid sequence of nematode myosin rod. (1983) (271)
- Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing (2015) (255)
- Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency (2008) (251)
- Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2 (2011) (241)
- Tackling Tat. (1999) (239)
- Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction (2010) (237)
- Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. (1996) (230)
- An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. (1997) (230)
- High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. (1993) (226)
- CBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency (2007) (219)
- Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. (2014) (213)
- A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. (1994) (197)
- Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. (1991) (178)
- The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit (2011) (170)
- Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation (2002) (169)
- Protein structural domains in the Caenorhabditis elegans unc-54 myosin heavy chain gene are not separated by introns. (1983) (165)
- Regulation of cell cycle duration by c-myc levels. (1989) (154)
- Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein (2009) (145)
- Activation of Human Immunodeficiency Virus Transcription in T Cells Revisited: NF-κB p65 Stimulates Transcriptional Elongation (2001) (134)
- Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". (2004) (130)
- Characterization of the non-histone nuclear proteins associated with rapidly labeled heterogeneous nuclear RNA. (1977) (130)
- Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. (1999) (129)
- Recruitment of TFIIH to the HIV LTR is a rate‐limiting step in the emergence of HIV from latency (2006) (128)
- Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. (2004) (127)
- Distribution of NG, NG,-dimethylarginine in nuclear protein fractions. (1977) (127)
- Paramyosin gene (unc-15) of Caenorhabditis elegans. Molecular cloning, nucleotide sequence and models for thick filament structure. (1989) (126)
- Immunological identification of the genes encoding the four myosin heavy chain isoforms of Caenorhabditis elegans. (1986) (123)
- RNA recognition by the human immunodeficiency virus Tat and Rev proteins. (1993) (119)
- The Molecular Basis for Human Immunodeficiency Virus Latency. (2017) (115)
- Sequence analysis of mutations that affect the synthesis, assembly and enzymatic activity of the unc-54 myosin heavy chain of Caenorhabditis elegans. (1985) (113)
- T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. (2011) (113)
- Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences (2002) (113)
- Early nuclear events in the induction of lymphocyte proliferation by mitogens. Effects of concanavalin A on the phosphorylation and distribution of non-histone chromatin proteins. (1974) (113)
- Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system (2016) (113)
- Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein. (1992) (111)
- Molecular analysis of the unc-54 myosin heavy-chain gene of Caenorhabditis elegans (1981) (105)
- Sequence analysis of the complete Caenorhabditis elegans myosin heavy chain gene family. (1989) (104)
- A new selective phage cloning vector, λ2001, with sites for XbaI, BamHI, HindIII, EcoRI, SstI and XhoI (1984) (101)
- Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir (2018) (98)
- Differential phosphorylation and turnover of nuclear acidic proteins during the cell cycle of synchronized HeLa cells. (1974) (97)
- Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms (2011) (97)
- Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. (1996) (88)
- Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency (2017) (85)
- Negative Elongation Factor Is Required for the Maintenance of Proviral Latency but Does Not Induce Promoter-Proximal Pausing of RNA Polymerase II on the HIV Long Terminal Repeat (2014) (83)
- Phosphorylation of CDK9 at Ser175 Enhances HIV Transcription and Is a Marker of Activated P-TEFb in CD4+ T Lymphocytes (2013) (81)
- Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. (1993) (79)
- Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells (2017) (79)
- Nucleotide sequence of tobacco mosaic virus RNA ( oligonucleotide primers / cDNA library / RNA polymorphism / eukaryotic ribosome binding / leaky amber termination ) (76)
- Molecular biology of HIV: new insights into the virus life‐cycle (1989) (74)
- Short-Chain Fatty Acids from Periodontal Pathogens Suppress Histone Deacetylases, EZH2, and SUV39H1 To Promote Kaposi's Sarcoma-Associated Herpesvirus Replication (2014) (72)
- Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins (1994) (68)
- Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. (1999) (68)
- An isotopic assay of cyclic 3',5'-nucleotide phosphodiesterase with aluminum oxide columns. (1973) (67)
- Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA (2011) (67)
- The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. (1995) (66)
- Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type‐1 transcription elongation complex (1997) (66)
- Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. (1996) (63)
- Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element. (1996) (61)
- Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. (1993) (61)
- Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells (2012) (59)
- The genes sup-7 X and sup-5 III of C. elegans suppress amber nonsense mutations via altered transfer RNA (1983) (59)
- Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA (2018) (58)
- Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation (2018) (53)
- The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of Postentry Viral Events (2014) (50)
- Cross-talk between microglia and neurons regulates HIV latency (2019) (47)
- Phosphorylation of DNA-binding nuclear acidic proteins and gene activation in the HeLa cell cycle. (1974) (47)
- HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function (2016) (46)
- New bacteriophage lambda vectors with positive selection for cloned inserts. (1983) (44)
- HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency (2017) (44)
- Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications. (2015) (43)
- Tobacco mosaic virus induces the synthesis of a family of 3' coterminal messenger RNAs and their complements. (1982) (42)
- Progress in anti-HIV structure-based drug design. (1995) (41)
- Phasmids: hybrids between ColE1 plasmids and E. coli bacteriophage lambda. (1982) (41)
- Negative Feedback Regulation of HIV-1 by Gene Editing Strategy (2016) (41)
- Sensitive detection of RNA using strand-specific M13 probes. (1982) (39)
- RNA binding by the tat and rev proteins of HIV-1. (1991) (35)
- The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency (2018) (32)
- Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation (2018) (32)
- New insights into the mechanism of HIV-1 trans-activation. (1992) (32)
- Entry of Polarized Effector Cells into Quiescence Forces HIV Latency (2019) (30)
- An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb (2018) (29)
- Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing (2016) (29)
- Tat , a novel regulator of HIV transcription and latency (2001) (27)
- Stimulation of Tat‐associated kinase‐independent transcriptional elongation from the human immunodeficiency virus type‐1 long terminal repeat by a cellular enhancer (1999) (27)
- Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes. (1991) (26)
- Novel bacteriophage X cloning vector (26)
- Regulatory and essential light-chain-binding sites in myosin heavy chain subfragment-1 mapped by site-directed mutagenesis. (1989) (26)
- The rapid non-polar transport of auxin in the phloem of intact Coleus plants (1974) (25)
- The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells (2018) (25)
- Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial (2016) (23)
- PHOSPHORYLATION OF NUCLEAR PROTEINS AT TIMES OF GENE ACTIVATION (1973) (23)
- Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. (2015) (22)
- Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P‐TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression (2015) (20)
- Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial (2022) (20)
- Methods in enzymology, vol. 152: guide to molecular cloning techniques: edited by Shelby L. Berger and Alan R. Kimmel, Academic Press, 1987. $89.00 (xl + 812 pages) ISBN 0-12-182053-X (1988) (19)
- A gene-specific role for the Ssu72 RNAPII CTD phosphatase in HIV-1 Tat transactivation (2014) (19)
- Glycolysis downregulation is a hallmark of HIV‐1 latency and sensitizes infected cells to oxidative stress (2021) (17)
- Bacterial Short Chain Fatty Acids Push All The Buttons Needed To Reactivate Latent Viruses. (2015) (17)
- Cloning nematode myosin genes. (1985) (17)
- Transformation of growth factor-dependent myeloid stem cells with retroviral vectors carrying c-myc. (1989) (17)
- Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis (2016) (15)
- A new BET on the control of HIV latency (2013) (14)
- A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315). (2020) (14)
- The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. (1995) (13)
- Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation (2021) (13)
- A new selective phage cloning vector, lambda 2001, with sites for XbaI, BamHI, HindIII, EcoRI, SstI and XhoI. (1984) (11)
- Sex differences in HIV Persistence and Reservoir Size during Aging. (2021) (10)
- The Influence of Blood pH on Peripheral Vascular Tone: Possible Role of Proteases and Vaso-Active Polypeptides (1970) (10)
- Cyclic nucleotide phosphodiesterases of Hyalophora cecropia silkmoth fat body. (1977) (9)
- Human immunodeficiency virus 1 tat protein binds transactivation-responsive region ( TAR ) RNA in vitro ( transactivation / RNA-binding proteins / gene synthesis / andsense RNA ) (9)
- Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR / Cas 9 Gene Editing SUPPLEMENTARY MATERIALS (2016) (8)
- Biochemistry, molecular biology, and drug discovery (1995) (8)
- Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation. (2018) (8)
- Synthesis and applications of oligoribonucleotides containing N4- methylcytidine (1995) (7)
- Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways (2021) (6)
- Methods for cDNA cloning and sequencing tobacco mosaic virus RNA. (1984) (5)
- The retroviridae (Vol. 1): Jay A. Levy Plenum Press, 1992, $95.00 hbk (xiv + 483 pages) ISBN 0 306 44074 1 (1993) (5)
- A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells (2021) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Selective effects of inhibitors of protein synthesis on metabolism of nuclear anc cytoplasmic proteins: evidence for coordinate synthesis of non-histone chromosomal proteins. (1975) (5)
- The HIV Tat-TAR interaction, a novel target for drug discovery (1998) (5)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Gene expression technology (methods in enzymology vol. 185): edited by D.V. Goeddel, Academic Press, 1990. $80.00 (xxxi + 681 pages) ISBN 0 12 182086 6 (1991) (4)
- Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells (2022) (4)
- Special issue: Structural and molecular biology of HIV. (2011) (3)
- Synthetic Ribonucleotide Analogues for RNA Structure-Function Studies (1995) (3)
- Oral immune dysfunction is associated with the expansion of FOXP3+PD-1+Amphiregulin+ T cells during HIV infection (2021) (3)
- Impact of Tamoxifen on Vorinostat-Induced HIV Expression in Women on Antiretroviral Therapy (ACTG A5366:The MOXIE trial). (2022) (3)
- Detecting Sources of Immune Activation and Viral Rebound in HIV Infection (2022) (3)
- A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy. (2020) (3)
- Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda (2022) (3)
- HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency (2017) (2)
- The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder. (2022) (2)
- Virology and immunology (1995) (2)
- Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies (2015) (2)
- ARG-BOUND TAR RNA, NMR (1996) (1)
- Viruses, Mark Thy Message Well. (2016) (1)
- COVID-19 plasma exosomes promote proinflammatory immune responses in peripheral blood mononuclear cells (2022) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- Research strategies for AIDS vaccine development and evaluation: the MRC programme. (1990) (1)
- Trans-Activation Requires the Binding of the HIV-1 Tat Protein to Tar RNA (1991) (1)
- Molecular biology of muscle development (1987) (1)
- Regulation of hiv 1 gene expression by the rna binding proteins tat and rev (1991) (1)
- Women undergoing reproductive aging show increased reservoir sizes associated with removal of hormonal control of HIV-1 latency by oestrogen (2019) (1)
- Effects of acetylcholine and concanavalin A on phosphorylation of lymphocyte chromatin proteins (1974) (1)
- New insights into transcription elongation control of HIV-1 latency and rebound. (2023) (1)
- OP 8.2 – 00033 Interleukin-2 administration is a potent latency reversal agent in people with treated HIV infection (2022) (1)
- Selective effects of inhibitors of protein synthesis on the metabolism of nuclear and cytoplasmic proteins (1975) (1)
- Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex ( RNA polymerase II / transactivation ) (2005) (0)
- Inhibition of the H3K27 demethylase UTX enhances the epigenetic 1 silencing of HIV proviruses and induces HIV-1 DNA hypermethylation (2021) (0)
- PD-1 dependent expansion of Amphregulin+FOXP3+ cells is associated with oral immune dysfunction in HIV patients on therapy (2021) (0)
- Preventing Premature RNA Release at Immunodeficiency Virus Type 1 Tat by Spt5 Cooperates with Human (2014) (0)
- PP 1.2 – 00011 Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar zone supportive of early transcription reactivation (2022) (0)
- F-101 Signaling Pathways and Epigenetic Mechanisms Controlling HIV Latency (2014) (0)
- Ligase / polymerase-mediated analysis of genetic elements of single nucleotide polymorphisms and their use in genetic analysis (1995) (0)
- Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains. (2023) (0)
- Sequence‐Specific Binding of DNA by Non‐Histone Proteins and Their Migration from Cytoplasm to Nucleus During Gene Activation (2008) (0)
- FRET-based competition assay to detect RNA binding compounds (1999) (0)
- Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system (2016) (0)
- Terminator Sequences Preventing Premature RNA Release at Immunodeficiency Virus Type 1 Tat by Spt 5 Cooperates with Human (2002) (0)
- Reduction of the HIV-1 reservoir in T cells from persons with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells ex vivo (2022) (0)
- PP 1.11 – 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal (2022) (0)
- PP 2.5 – 00041 HIV persistence and latency in microglia: Single-cell transcriptome analysis of three humanized mice models of HAND shows viral responses to inflammatory signaling (2022) (0)
- Erratum: Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge (Nucleic Acids Research (1996) 24 (3974-3981)) (1996) (0)
- Tat transactivation A gene-specific role for the Ssu 72 RNAPII CTD phosphatase in HIV-1 Material Supplemental (2014) (0)
- Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary. (2023) (0)
- Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir (2019) (0)
- The Nerve Growth Factor IB-like Receptor Nurr1 (NR4A2) Recruits CoREST 2 Transcription Repressor Complexes to Silence HIV Following Proviral Reactivation 3 in Microglial Cells (2021) (0)
- Mobilizing NK cells for an HIV Cure: NK cells can target and kill latently HIV-1-infected primary T cells following proviral reactivation (2017) (0)
- Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda (2022) (0)
- [Murine retrovirus vector expressing env gene of human immunodeficiency virus type 1 (HIV-1)]. (1991) (0)
- The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells (2018) (0)
- CIS-ACTING RNA REGULATORY ELEMENT (HIV-1 TAR), NMR, 20 STRUCTURES (1997) (0)
- Visualisation of HIV reactivation from latency in primary resting memory T-cells (2019) (0)
- Designed HIV-1 TAR Binding Ligand (2004) (0)
- Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA (2018) (0)
- A Reliable Primary Cell Model for HIV Latency: The QUECEL (Quiescent Effector Cell Latency) Method. (2022) (0)
- The Nerve Growth Factor IB-like Receptor Nurr1 (NR4A2) Recruits CoREST Transcription Repressor Complexes to Silence HIV Following Proviral Reactivation in Microglial Cells (2021) (0)
- The histone deacetylase inhibitor vorinostat ( SAHA ) increases the susceptibility of uninfected 1 CD 4 + T cells to HIV by increasing the kinetics and efficiency of post-entry viral events 2 3 (2014) (0)
- An inhibitor of the Tat (cid:121) TAR RNA interaction that effectively suppresses HIV-1 replication (1997) (0)
- A-104 Distinct mechanisms of hormonal control of HIV latency in T-cells and microglial cells (2016) (0)
- An HIV-induced mechanism for T cell quiescence and proviral latency (2021) (0)
- NMR structure of a synthetic small molecule, rbt203, bound to HIV-1 TAR RNA (2004) (0)
- Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells (2012) (0)
- NMR structure of a synthetic small molecule, rbt158, bound to HIV-1 TAR RNA (2004) (0)
- HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA. (1993) (0)
- PP 1.3 – 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells (2022) (0)
- Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jonathan Karn?
Jonathan Karn is affiliated with the following schools:
